STOCK TITAN

Akari Therapeutics interim CFO reports two stock awards

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Akari Therapeutics Plc (AKTX) Interim CFO Kameel D. Farag reported two award acquisitions on November 17, 2026: 1,284 American Depositary Shares representing ordinary shares with a reported per-share price of $10.12, and 1,589 with a reported per-share price of $8.18. The footnote identifies the ADS as representing restricted stock units; each RSU represents the right to receive 80,000 ordinary shares, and the RSUs vest in full on November 15, 2026.

Insider Farag Kameel D.
Role Interim CFO
Type Security Shares Price Value
Grant/Award American Depositary Shares representing Ordinary Shares F1 1,284 $10.12 $13K
Grant/Award American Depositary Shares representing Ordinary Shares F1 1,589 $8.18 $13K
Holdings After Transaction: American Depositary Shares representing Ordinary Shares — 26,182 shares (Direct)
Holdings Before and After: American Depositary Shares representing Ordinary Shares, 23,309 to 26,182 shares (Direct)
Footnotes (1)
  1. F1. These American Depositary Shares represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. The RSUs will vest in full on November 15, 2026.
ADS award 1,284 ADS November 17, 2026; reported per-share price of $10.12
Per-share price $10.12 per share 1,284 ADS award reported for November 17, 2026
ADS award 1,589 ADS November 17, 2026; reported per-share price of $8.18
Per-share price $8.18 per share 1,589 ADS award reported for November 17, 2026
Ordinary shares per RSU 80,000 ordinary shares Each RSU represents the right to receive this number of ordinary shares
RSU vesting date November 15, 2026 RSUs vest in full
restricted stock units (RSUs) financial
"the RSUs represented by the two award acquisitions reported for November 17, 2026"
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many AKTX ADS did Interim CFO Kameel D. Farag receive?

Farag reported awards of 1,284 ADS and 1,589 ADS on November 17, 2026. The reported per-share prices were $10.12 and $8.18, respectively. The ADS represent restricted stock units, each representing the right to receive 80,000 ordinary shares; the RSUs vest in full on November 15, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Farag Kameel D.

(Last)(First)(Middle)
C/O AKARI THERAPEUTICS PLC
401 EAST JACKSON STREET, SUITE 3300

(Street)
TAMPA FLORIDA 33602

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Akari Therapeutics Plc [ AKTX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Interim CFO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/17/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
American Depositary Shares representing Ordinary Shares11/17/2026A1,284(1)A$10.1224,593D
American Depositary Shares representing Ordinary Shares11/17/2026A1,589(1)A$8.1826,182D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. These American Depositary Shares represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. The RSUs will vest in full on November 15, 2026.
/s/ Abizer Gaslightwala, as Attorney-in-Fact11/19/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading